A handful of clinical trials are underway to find out whether drugs that target senescent cells can slow the ravages of old age.

With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.

With deep learning methods revolutionizing life sciences, researchers bet on de novo proteins and cell mapping models to deliver customized precision medicines.

Clinical trials that target human endogenous retroviruses to treat multiple sclerosis, ALS, and other ailments are underway, but many questions remain about how these sequences may disrupt our biology.

Noncoding RNAs are proving to be critical players in the evolution of brain anatomy and cognitive complexity.

How to Clone a Mammoth, The Upright Thinkers, The Thirteenth Step, and Humankind

Junk DNA, Cuckoo, Sapiens, and Cool

In chapter 5, “Resurgence: Bedbugs Bite Back,” author Emily Monosson chronicles the rise of the pesky pests in the face of humanity’s best chemical efforts.

Damaged lysosomes are repaired by a lipid-based signaling pathway dubbed PITT that could be targeted to treat neurodegenerative disease, its discoverers say.

The modern human brain evolved in social and environmental settings very unlike today’s. Despite our cultural and technological progress, tribal instincts remain.